JP7151070B2 - 粒子およびその製造方法 - Google Patents

粒子およびその製造方法 Download PDF

Info

Publication number
JP7151070B2
JP7151070B2 JP2017186885A JP2017186885A JP7151070B2 JP 7151070 B2 JP7151070 B2 JP 7151070B2 JP 2017186885 A JP2017186885 A JP 2017186885A JP 2017186885 A JP2017186885 A JP 2017186885A JP 7151070 B2 JP7151070 B2 JP 7151070B2
Authority
JP
Japan
Prior art keywords
particles
cellulose
polymer
active ingredient
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017186885A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018059086A (ja
JP2018059086A5 (https=
Inventor
渉 涌井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of JP2018059086A publication Critical patent/JP2018059086A/ja
Publication of JP2018059086A5 publication Critical patent/JP2018059086A5/ja
Application granted granted Critical
Publication of JP7151070B2 publication Critical patent/JP7151070B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2017186885A 2016-09-30 2017-09-27 粒子およびその製造方法 Active JP7151070B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016194659 2016-09-30
JP2016194659 2016-09-30

Publications (3)

Publication Number Publication Date
JP2018059086A JP2018059086A (ja) 2018-04-12
JP2018059086A5 JP2018059086A5 (https=) 2019-05-09
JP7151070B2 true JP7151070B2 (ja) 2022-10-12

Family

ID=61908420

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017186885A Active JP7151070B2 (ja) 2016-09-30 2017-09-27 粒子およびその製造方法

Country Status (1)

Country Link
JP (1) JP7151070B2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6743841B2 (ja) * 2018-03-26 2020-08-19 株式会社三洋物産 遊技機
GB202318661D0 (en) * 2023-12-06 2024-01-17 Crystec Ltd Tranexamic acid compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007099631A (ja) 2005-09-30 2007-04-19 Hosokawa Funtai Gijutsu Kenkyusho:Kk アニオン性薬物封入ナノ粒子の製造方法及びそれを用いた医薬製剤
JP2013538882A (ja) 2010-07-15 2013-10-17 ユニリーバー・ナームローゼ・ベンノートシヤープ 有益剤送達粒子、前記粒子を調製するための方法、前記粒子を含む組成物および基質を処理するための方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007099631A (ja) 2005-09-30 2007-04-19 Hosokawa Funtai Gijutsu Kenkyusho:Kk アニオン性薬物封入ナノ粒子の製造方法及びそれを用いた医薬製剤
JP2013538882A (ja) 2010-07-15 2013-10-17 ユニリーバー・ナームローゼ・ベンノートシヤープ 有益剤送達粒子、前記粒子を調製するための方法、前記粒子を含む組成物および基質を処理するための方法

Also Published As

Publication number Publication date
JP2018059086A (ja) 2018-04-12

Similar Documents

Publication Publication Date Title
Zeng et al. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability
Müller et al. Rhamnolipids form drug-loaded nanoparticles for dermal drug delivery
Abioye et al. Ex vivo skin permeation and retention studies on chitosan–ibuprofen–gellan ternary nanogel prepared by in situ ionic gelation technique—a tool for controlled transdermal delivery of ibuprofen
Zhou et al. In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis
Khan et al. Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein
Lee et al. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs
JP6933465B2 (ja) 難水溶性化合物のための医薬組成物
CN102573913B (zh) 可生物降解的基于聚乙二醇的水不溶性水凝胶
Praphakar et al. Targeted delivery of rifampicin to tuberculosis-infected macrophages: design, in-vitro, and in-vivo performance of rifampicin-loaded poly (ester amide) s nanocarriers
JP4237446B2 (ja) トコフェロール誘導体を用いてナノ乳化粒子を安定化させる方法及びナノ乳化粒子を含有する皮膚外用剤組成物
JP5485879B2 (ja) 異なる物性の薬物の一剤形化
JP2022183357A (ja) 外用組成物
WO2011088688A1 (zh) 以氨基酸为稳定剂的聚合物胶束载药系统
Noor et al. Formulation and evaluation of ondansetron HCl nanoparticles for transdermal delivery
He et al. Preparation and in vitro–in vivo evaluation of teniposide nanosuspensions
KR20170117438A (ko) 지질펩티드형 화합물을 함유하는 경피흡수기재
JP7151070B2 (ja) 粒子およびその製造方法
JP2010254691A (ja) コーティングされた凍結乾燥成型品
Ozkan et al. An overview of excipients classification and their use in pharmaceuticals
US9180195B2 (en) Controlled release gels
JP5548362B2 (ja) 油溶性活性成分を捕集した陽イオン性高分子ナノカプセル及びこれを含有する化粧料組成物
Mohammed et al. Investigation of solubility enhancement approaches of ticagrelor
JP7222236B2 (ja) 経口固形組成物
Audu et al. Phospholipon 90G based SLMs loaded with ibuprofen: An oral anti-inflammatory and gastrointestinal sparing evaluation in rats
JP7222232B2 (ja) 徐放性外用剤組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180514

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190322

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200629

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210727

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210921

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211125

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220412

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220712

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20220712

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20220721

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20220726

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220830

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220912

R150 Certificate of patent or registration of utility model

Ref document number: 7151070

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250